CCL5 and tuberculosis: All six studies were pooled together which resulted into 1638 confirm TB cases and 1519 controls, and the random effects model (based on heterogeneity) was employed to evaluate the overall association between the CCL5 -409 G>A polymorphism and TB susceptibility.